Dr. Bozoki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
170 Manning Drive, CB 7025
Chapel Hill, NC 27599Phone+1 919-843-1220
Summary
- I am a research-focused neurologist with interests in clinical trials of anti-dementia therapies and multi-modal theragnostic biomarker development.
Education & Training
- University of Michigan Health SystemFellowship, Behavioral and Geriatric Neurology, 1999 - 2001
- University of Michigan Health SystemFellowship, Behavioral Neurology, 1997 - 1999
- University of MichiganResidency, Neurology, 1994 - 1997
- Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1993 - 1994
- State University of New York Downstate Medical Center College of MedicineClass of 1993
Certifications & Licensure
- NC State Medical License 2020 - 2025
- MI State Medical License 1997 - 2022
- IN State Medical License 2020 - 2021
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 1 citationsSource-free collaborative domain adaptation via multi-perspective feature enrichment for functional MRI analysis.Yuqi Fang, Jinjian Wu, Qianqian Wang, Shijun Qiu, Andrea Bozoki
Pattern Recognition. 2025-01-01 - 4 citationsAlzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation.Bruno Dubois, Nicolas Villain, Lon Schneider, Nick Fox, Noll Campbell
JAMA Neurology. 2024-12-01 - Gene-Specific Effects on Brain Volume and Cognition ofin Frontotemporal Lobar Degeneration.Marijne Vandebergh, Eliana Marisa Ramos, Nick Corriveau-Lecavalier, Vijay K Ramanan, John Kornak
Neurology. 2024-10-22
Press Mentions
- Duke, UNC Awarded Grant to Establish Joint Alzheimer’s Disease Research CenterSeptember 9th, 2021
- Clinical Effects of the Self-Administered Subcutaneous Complement Inhibitor Zilucoplan in Patients with Moderate to Severe Generalized Myasthenia GravisFebruary 17th, 2020
- The Plan to Diagnose Alzheimer’s in People with No Memory ProblemsFebruary 15th, 2024
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- Hungarian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: